🇺🇸 FDA
Patent

US 9476051

Antisense modulation of superoxide dismutase 1, soluble expression

granted A61KA61K38/00A61P

Quick answer

US patent 9476051 (Antisense modulation of superoxide dismutase 1, soluble expression) held by Ionis Pharmaceuticals, Inc. expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P21/00, A61P25/00